Combination of a Derivative of 6 - oxo - 1.6 - dihydro - pyridazine hydrochloride has anti-cancer activity with an inhibitor of epidermal growth factor receptor (EGFR)
The pharmaceutical components include 3 - (1 - [3 - [5 - (1-methyl-piperidin-4-ilmeroxi) - pirimidin-2-il] - bencil} - 6-oxo-1, 6-dihydro-piridazin-3-il) benzoate, which is called amphetamine, Or with N - (3 - [[2 - [4 - (4 -) (4 - (4-acetylpyridine-1-il) - 2-methoxy-anilino] - 5 - (trifluoromethyl) pyridine-4-il) amine] phenyl-2-corresponding amine, known as spray B； drug ingredients are used in cancer treatment.composición farmacéutica que comprende 3-(1-[3-[5-(1-metil-piperidin-4-ilmetoxi)-pirimidin-2-il]-bencil}-6-oxo-1,6-dihidro-piridazin-3-il)benzonitrilo, conocido comoTepotinib, o una sal y/o solvato farmacéuticamente aceptable del mismo en combinación con N-(3-[[2-[4-(4-acetilpiperazin-1-il)-2-metoxi-anilino] -5-(trifluorometil)pirimidin-4-il]amino]fenil-2-enamida, conocido como Rociletinib； Uso de la composición farmacéutica en el tratamiento del cáncer.
